Search - tctmd.com

Displaying 221 - 240 of 243

Sort: Relevancy | Date

News Conference News TCT 2016

New BRS Studies Show Promise for Second-Generation Devices With Thinner Struts

Yael L. Maxwell

October 31, 2016

Presentation TCT 2016

FUTURE-I: Six-Month Clinical, Angiographic, IVUS, and OCT Results With a Thin-Strut PLLA-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease

Presenter: Patrick W. Serruys, Joanna J. Wykrzykowska, Bo Xu

October 31, 2016

Presentation TCT 2016

FORTITUDE: Nine-Month Clinical, Angiographic, and OCT Results With an Amorphous PLLA-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease

Presenter: Patrick W. Serruys, Joanna J. Wykrzykowska, Antonio Colombo

October 31, 2016

Presentation TCT 2016

MeRes-1: Six-Month Clinical, Angiographic, IVUS, and OCT Results With a Thin-Strut PLLA-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease

Presenter: Patrick W. Serruys, Joanna J. Wykrzykowska, Ashok Seth

October 31, 2016

Presentation TCT 2016

FANTOM II: Six-Month and Nine-Month Clinical and Angiographic Results With a Radiopaque Desaminotyrosine Polycarbonate-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease

Presenter: Patrick W. Serruys, Joanna J. Wykrzykowska, Alexandre Abizaid

October 31, 2016

Presentation TCT 2016

REVELUTION: Nine-Month Clinical, Angiographic, IVUS, and OCT Outcomes With a Polymer-Free Sirolimus-Eluting Drug-Filled Stent

Presenter: Patrick W. Serruys, Joanna J. Wykrzykowska, Stephen G. Worthley

October 31, 2016

News Daily News

Ipsilateral Ulnar Compression Significantly Reduces Risk of Radial Artery Occlusion After Transradial PCI

Michael O'Riordan

October 03, 2016

News Opinion Editor's Corner

ESC 2016: Bare-Metal Flashbacks, Coronary Imaging Comparisons, Heart Team Hype, and His Holiness

Shelley Wood

August 24, 2016

News Daily News

PLATFORM: FFRCT-Guided Strategy in Suspected CAD ‘Durable’ Out to 1 Year

Michael O'Riordan

July 27, 2016

News Daily News

PLATFORM: Ante Sospecha de EAC la Estrategia de Guiado mediante FFRTC ‘Tiene una Duración’ de 1 Año

Michael O'Riordan

July 27, 2016

News Daily News

PLATFORM：FFRCT 指导的策略在疑似 CAD 患者中可“坚持”到 1 年

Michael O'Riordan

July 27, 2016

Presentation CCVVC 2016

Anti-Thrombotic Therapy for PCI

Presenter: Deepak L. Bhatt

June 16, 2016

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for March 2016

Shelley Wood

March 30, 2016

Presentation Intravascular Coronary Imaging and Physiology 2016

How I Optimize Stent Implantation

Presenter: Jeffrey W. Moses

March 11, 2016

Presentation Intravascular Coronary Imaging and Physiology 2016

Use Imaging to Optimize and Understand BRS

Presenter: Alexandre Abizaid

March 10, 2016

Presentation Intravascular Coronary Imaging and Physiology 2016

Role of OCT in Evaluation and treatment of In Stent Restenosis

Presenter: Andrew Lituchy

March 10, 2016

Presentation Intravascular Coronary Imaging and Physiology 2016

How (and Why) Do I Assess Causes of Stent Thrombosis and Restenosis?

Presenter: Ajay J. Kirtane

March 10, 2016

Presentation JIM 2016

Novel Imaging and Physiologic Lesion Assessment Devices to Guide BRS procedures

Presenter: Azeem Latib

February 10, 2016

Presentation JIM 2016

Bioresorbable Vascular Scaffolds for Chronic Total Occlusions: Clinical and Multi-imaging follow-up Outcomes

Presenter: Antonio Serra

February 10, 2016

Presentation Physiology and Intravascular Imaging 2014

Update on Neoatherosclerosis: A Novel Form of Stent Failure

Presenter: Ziad A. Ali

March 27, 2014

Advertisement

New BRS Studies Show Promise for Second-Generation Devices With Thinner Struts

FUTURE-I: Six-Month Clinical, Angiographic, IVUS, and OCT Results With a Thin-Strut PLLA-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease

FORTITUDE: Nine-Month Clinical, Angiographic, and OCT Results With an Amorphous PLLA-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease

MeRes-1: Six-Month Clinical, Angiographic, IVUS, and OCT Results With a Thin-Strut PLLA-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease

FANTOM II: Six-Month and Nine-Month Clinical and Angiographic Results With a Radiopaque Desaminotyrosine Polycarbonate-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease

REVELUTION: Nine-Month Clinical, Angiographic, IVUS, and OCT Outcomes With a Polymer-Free Sirolimus-Eluting Drug-Filled Stent

Ipsilateral Ulnar Compression Significantly Reduces Risk of Radial Artery Occlusion After Transradial PCI

ESC 2016: Bare-Metal Flashbacks, Coronary Imaging Comparisons, Heart Team Hype, and His Holiness

PLATFORM: FFRCT-Guided Strategy in Suspected CAD ‘Durable’ Out to 1 Year

PLATFORM: Ante Sospecha de EAC la Estrategia de Guiado mediante FFRTC ‘Tiene una Duración’ de 1 Año

PLATFORM：FFRCT 指导的策略在疑似 CAD 患者中可“坚持”到 1 年

Anti-Thrombotic Therapy for PCI

TCTMD’s Top 10 Most Popular Stories for March 2016

How I Optimize Stent Implantation

Use Imaging to Optimize and Understand BRS

Role of OCT in Evaluation and treatment of In Stent Restenosis

How (and Why) Do I Assess Causes of Stent Thrombosis and Restenosis?

Novel Imaging and Physiologic Lesion Assessment Devices to Guide BRS procedures

Bioresorbable Vascular Scaffolds for Chronic Total Occlusions: Clinical and Multi-imaging follow-up Outcomes

Update on Neoatherosclerosis: A Novel Form of Stent Failure

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content